Filing metadata

Accession number
0001567619-21-014220
Form type
Form 4
Filer
Eiger BioPharmaceuticals, Inc.
CIK
CIK 1305253
Filed
Jul 30, 2021
Reporting period
Jul 29, 2021
Description
Insider transaction

Explore SEC Filings Hub